172 related articles for article (PubMed ID: 22198631)
41. The prevention and treatment effects of tanshinone IIA on oestrogen/androgen-induced benign prostatic hyperplasia in rats.
Wang C; Du X; Yang R; Liu J; Xu D; Shi J; Chen L; Shao R; Fan G; Gao X; Tian G; Zhu Y; Zhang J
J Steroid Biochem Mol Biol; 2015 Jan; 145():28-37. PubMed ID: 25290459
[TBL] [Abstract][Full Text] [Related]
42. Complementary and alternative medications for benign prostatic hyperplasia.
Keehn A; Lowe FC
Can J Urol; 2015 Oct; 22 Suppl 1():18-23. PubMed ID: 26497340
[TBL] [Abstract][Full Text] [Related]
43. Potential efficacy of some african plants in benign prostatic hyperplasia and prostate cancer.
Russo GI; Cimino S; Salamone C; Madonia M; Favilla V; Castelli T; Morgia G
Mini Rev Med Chem; 2013 Oct; 13(11):1564-71. PubMed ID: 23713889
[TBL] [Abstract][Full Text] [Related]
44. A Vitex agnus-castus extract inhibits cell growth and induces apoptosis in prostate epithelial cell lines.
Weisskopf M; Schaffner W; Jundt G; Sulser T; Wyler S; Tullberg-Reinert H
Planta Med; 2005 Oct; 71(10):910-6. PubMed ID: 16254821
[TBL] [Abstract][Full Text] [Related]
45. The effect of LHRH antagonist cetrorelix in crossover conditioned media from epithelial (BPH-1) and stromal (WPMY-1) prostate cells.
Siejka A; Schally AV; Barabutis N
Horm Metab Res; 2014 Jan; 46(1):21-6. PubMed ID: 23839655
[TBL] [Abstract][Full Text] [Related]
46. Flaxseed suppressed prostatic epithelial proliferation in a rat model of benign prostatic hyperplasia.
Said MM; Hassan NS; Schlicht MJ; Bosland MC
J Toxicol Environ Health A; 2015; 78(7):453-65. PubMed ID: 25785559
[TBL] [Abstract][Full Text] [Related]
47. Cytotoxicity of herbal extracts used for treatment of prostatic disease on head and neck carcinoma cell lines and non-malignant primary mucosal cells.
Schmidt M; Polednik C; Roller J; Hagen R
Oncol Rep; 2013 Feb; 29(2):628-36. PubMed ID: 23165347
[TBL] [Abstract][Full Text] [Related]
48. Low-dose tadenan protects the rabbit bladder from bilateral ischemia/ reperfusion-induced contractile dysfunction.
Levin RM; Whitbeck C; Horan P; Bellamy F
Phytomedicine; 2005 Jan; 12(1-2):17-24. PubMed ID: 15693703
[TBL] [Abstract][Full Text] [Related]
49. Effect of a standardized extract of red orange juice on proliferation of human prostate cells in vitro.
Vitali F; Pennisi C; Tomaino A; Bonina F; De Pasquale A; Saija A; Tita B
Fitoterapia; 2006 Apr; 77(3):151-5. PubMed ID: 16530345
[TBL] [Abstract][Full Text] [Related]
50. Herbs for benign prostatic hyperplasia.
Dvorkin L; Song KY
Ann Pharmacother; 2002 Sep; 36(9):1443-52. PubMed ID: 12196065
[TBL] [Abstract][Full Text] [Related]
51. Phytotherapy for Benign Prostatic Hyperplasia.
Keehn A; Taylor J; Lowe FC
Curr Urol Rep; 2016 Jul; 17(7):53. PubMed ID: 27180172
[TBL] [Abstract][Full Text] [Related]
52. Impact of phytotherapy on utility scores for 5 benign prostatic hyperplasia/lower urinary tract symptoms health states.
Dedhia RC; Calhoun E; McVary KT
J Urol; 2008 Jan; 179(1):220-5. PubMed ID: 18001791
[TBL] [Abstract][Full Text] [Related]
53. Rice Hull Extract Suppresses Benign Prostate Hyperplasia by Decreasing Inflammation and Regulating Cell Proliferation in Rats.
Kim CY; Chung KS; Cheon SY; Lee JH; Park YB; An HJ
J Med Food; 2016 Aug; 19(8):746-54. PubMed ID: 27441629
[TBL] [Abstract][Full Text] [Related]
54. Effect of oral Tadenan treatment on rabbit bladder structure and function after partial outlet obstruction.
Levin RM; Hass MA; Bellamy F; Horan P; Whitbeck K; Chow PH; Kung LS; Gosling J
J Urol; 2002 May; 167(5):2253-9. PubMed ID: 11956488
[TBL] [Abstract][Full Text] [Related]
55. Pygeum africanum (Prunus africanus) (African plum tree). Monograph.
Altern Med Rev; 2002 Feb; 7(1):71-4. PubMed ID: 11896748
[No Abstract] [Full Text] [Related]
56. The therapeutic effects of docosahexaenoic acid on oestrogen/androgen-induced benign prostatic hyperplasia in rats.
Wang C; Luo F; Zhou Y; Du X; Shi J; Zhao X; Xu Y; Zhu Y; Hong W; Zhang J
Exp Cell Res; 2016 Jul; 345(2):125-33. PubMed ID: 25849092
[TBL] [Abstract][Full Text] [Related]
57. [Phytotherapy in urology. Current scientific evidence of its application in benign prostatic hyperplasia and prostate adenocarcinoma].
Morán E; Budía A; Broseta E; Boronat F
Actas Urol Esp; 2013 Feb; 37(2):114-9. PubMed ID: 23058996
[TBL] [Abstract][Full Text] [Related]
58. Benign prostatic hyperplasia.
Webber R
Clin Evid; 2006 Jun; (15):1213-26. PubMed ID: 16973049
[No Abstract] [Full Text] [Related]
59. The role of phytotherapy in treating lower urinary tract symptoms and benign prostatic hyperplasia.
Dreikorn K
World J Urol; 2002 Apr; 19(6):426-35. PubMed ID: 12022711
[TBL] [Abstract][Full Text] [Related]
60. A phase II randomised double-blind placebo-controlled clinical trial investigating the efficacy and safety of ProstateEZE Max: a herbal medicine preparation for the management of symptoms of benign prostatic hypertrophy.
Coulson S; Rao A; Beck SL; Steels E; Gramotnev H; Vitetta L
Complement Ther Med; 2013 Jun; 21(3):172-9. PubMed ID: 23642948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
